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Abstract
Cardiovascular magnetic resonance (CMR) is increasingly used to assess patients with mitral regurgitation. Its advantages
include quantitative determination of ventricular volumes and function and the mitral regurgitant fraction, and in ischemic
mitral regurgitation, regional myocardial function and viability. In addition to these, identification of leaflet prolapse or
restriction is necessary when valve repair is contemplated. We describe a systematic approach to the evaluation of mitral
regurgitation using CMR which we have used in 149 patients with varying etiologies and severity of regurgitation over a
15 month period.
Following standard ventricular cine acquisitions, including 2, 3 and 4 chamber long axis views and a short axis stack for
biventricular function, we image movements of all parts of the mitral leaflets using a contiguous stack of oblique long axis
cines aligned orthogonal to the central part of the line of coaptation. The 8–10 slices in the stack, orientated
approximately parallel to a 3-chamber view, are acquired sequentially from the superior (antero-lateral) mitral
commissure to the inferior (postero-medial) commissure, visualising each apposing pair of anterior and posterior leaflet
scallops in turn (A1-P1, A2-P2 and A3-P3). We use balanced steady state free precession imaging at 1.5 Tesla, slice
thickness 5 mm, with no inter-slice gaps. Where the para-commissural coaptation lines curve relative to the central
region, two further oblique cines are acquired orthogonal to the line of coaptation adjacent to each commissure. To
quantify mitral regurgitation, we use phase contrast velocity mapping to measure aortic outflow, subtracting this from
the left ventricular stroke volume to calculate the mitral regurgitant volume which, when divided by the left ventricular
stroke volume, gives the mitral regurgitant fraction. In patients with ischemic mitral regurgitation, we further assess
regional left ventricular function and, with late gadolinium enhancement, myocardial viability.
Comprehensive assessment of mitral regurgitation using CMR is feasible and enables determination of mitral
regurgitation severity, associated leaflet prolapse or restriction, ventricular function and viability in a single examination
and is now routinely performed at our centre. The mitral valve stack of images is particularly useful and easy to acquire.
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Background
Mitral regurgitation is a relatively common and important
heart valve lesion in clinical practice, and adequate assess-
ment is fundamental to decisions on management.
Patients with less than severe mitral regurgitation are gen-
erally managed conservatively with medical treatment
whereas patients with severe mitral regurgitation are con-
sidered for surgery, especially if the left ventricle (LV)
shows signs of dilation or impairment of function, or if
the patient is symptomatic [1]. Increasingly, asympto-
matic patients with relatively normal LV function and
only mild LV dilatation are considered for mitral valve
repair rather than replacement as this has been shown to
improve long term outcome and the risk of surgery is low
[1]. Assessment of the severity of regurgitation, the dys-
function responsible for it (leaflet prolapse or restriction),
the etiology of the condition (degenerative, ischemic,
rheumatic, cardiomyopathy), and LV size and function,
are each important. Additional investigations may be
indicated, particularly in ischemic mitral regurgitation,
where evaluation of coronary artery lesions, myocardial
viability and contractile reserve are relevant.
Echocardiography is the recognised investigation of
choice for mitral regurgitation [1]. However, the tech-
nique is operator dependent and may not always give
optimal diagnostic views of mitral valve dysfunction.
Transesophageal echocardiography, with 3 dimensional
visualisation if available, generally gives a greater overall
assessment of mitral valve dysfunction and the lesions
responsible for it, but is also operator dependent, semi-
invasive and usually requires patient sedation.
Although cardiovascular magnetic resonance (CMR) is
not as widely used in the assessment of mitral regurgita-
tion, it has significant strengths. These include accurate
determination of left as well as right ventricular volumes
and function [2,3], measurements of aortic flow volume,
and in ischemic mitral regurgitation, comprehensive
assessment of regional myocardial function and viability
[2,4]. Although quantification of the severity of mitral
regurgitation using CMR is well established [3,5-7],
assessment of the valve dysfunction responsible for it
requires acquisitions planned with respect to mitral struc-
ture and movement. Dedicated cine imaging planes in
addition to the standard long axis views are needed to
assess movements of each scallop of each leaflet of the
mitral valve. When used optimally, CMR can complement
echocardiography in the assessment of mitral regurgita-
tion, especially in patients in whom transthoracic
echocardiography has not provided adequate informa-
tion.
Mitral valve anatomy
An understanding of the anatomy of the mitral valve is
required for optimal imaging. The valve consists of two
leaflets: anterior (or antero-septal) and posterior (or pos-
tero-lateral). Each leaflet is divided, from top to bottom,
into 3 scallops: A1, A2 and A3 of the anterior leaflet and
P1, P2 and P3 of the posterior leaflet (Fig 1) [8]. The
mitral valve leaflets are inserted at the base of the LV at the
annulus, and their free edges are attached by multiple
chordae tendinae to the papillary muscles. Adequate
coaptation of the free edges of the valve leaflets is neces-
sary to achieve valve competency. Degenerative mitral
valve disease or myxomatous degeneration of the leaflets
with redundant or thickened leaflet tissue, or ruptured or
elongated chordae or papillary muscles, typically results
in leaflet prolapse and regurgitation. The prolapse may
involve the entire leaflet or, more commonly, only one or
two scallops. It is important to determine both the loca-
tion and extent of the leaflet prolapse e.g. posterior leaflet
prolapse at P2 and P3, or anterior leaflet prolapse at A2,
etc. This is necessary to determine the type of surgery most
likely to be successful (mitral valve repair or replacement)
and the extent of surgical repair needed. Mitral regurgita-
tion from prolapse of P2, for example, is generally amena-
ble to surgical repair whereas anterior leaflet prolapse is
generally more challenging.
Mitral imaging technique
We use balanced steady state free precession (bSSFP) end-
expiratory breath hold cines, retrospective ECG gating,
temporal resolution of 20–30 ms, echo time 1.13 ms, in-
plane pixel size 1.7 × 1.7 mm, flip angle 80 degrees, FOV
read 320 mm, FOV phase 220 mm, base resolution 192
pixels, and acquisition time 16 heart beats. Following
standard imaging sequences, including cines of 2, 3 and 4
chamber long axis views and a short axis stack (starting at
the mitral annulus and continuing to the LV apex using a
slice thickness of 8 mm and a 2 mm gap), the mitral valve
is thoroughly imaged. A principle that is fundamental to
CMR cine imaging of thin structures or boundaries such as
those of mitral leaflets or jets is illustrated (Fig 2). A basal
short axis slice which shows the mitral valve is selected
(Fig 1). From this, a contiguous stack of oblique slices are
aligned orthogonal to the central part of the line of coap-
tation, orientated approximately parallel to the 3-cham-
ber LVOT long axis plane. The stack of cines acquired
starts from the superior (antero-lateral) commissure adja-
cent to A1-P1 and progresses towards the inferior (pos-
tero-medial) commissure adjacent to A3-P3 using a slice
thickness of 5 mm and no inter-slice gap (Fig 3). Typically,
2–3 slices pass through each of the valve scallops (A1-P1,
A2-P2, A3-P3). A further pair of oblique slices is acquired
orthogonal to the oblique line of leaflet coaptation at each
end of the valve adjacent to the commissures (across A1-
P1 and A3-P3) (Fig 4). These additional slices help to vis-Journal of Cardiovascular Magnetic Resonance 2008, 10:61 http://www.jcmr-online.com/content/10/1/61
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ualise the leaflets and their function in the commissural
region where their orientation is oblique to the initial cine
stack (Figs 3 and 4). From the mitral stack and commis-
sural images, each scallop of the mitral valve leaflet (A1-
P1, A2-P2, A3-P3) can be identified and any dysfunction
defined (Fig 5). Phase-contrast through-plane velocity
mapping of aortic and pulmonary artery flows are next
performed using a previously described technique to
allow quantification of the severity of mitral regurgitation
[9]. We perform aortic velocity mapping in the ascending
aorta immediately above the sino-tubular junction. In
patients with ischemic mitral regurgitation, we further
assess LV viability by inversion recovery late gadolinium
imaging, and contractile reserve by low dose dobutamine
stress at 5 and 10 mcg/kg/min as previously described
[2,10]. The imaging protocol for assessing mitral regurgi-
tation is summarised in the Appendix.
Anatomy of the mitral valve Figure 1
Anatomy of the mitral valve. CMR short axis view of the mitral valve from a basal short axis slice showing its two leaflets 
(anterior and posterior) and the three scallops of each leaflet (A1, A2 and A3 in the anterior leaflet, P1, P2 and P3 in the pos-
terior leaflet). The mitral valve is viewed from the LV looking towards the left atrium.Journal of Cardiovascular Magnetic Resonance 2008, 10:61 http://www.jcmr-online.com/content/10/1/61
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Interpretation
The current recommendation for the assessment of mitral
valve dysfunction as proposed by Carpentier and adopted
by the American College of Cardiology focuses on the
anatomic location and physiologic mechanism of the
valve dysfunction and aims to help the surgeon in plan-
ning surgical repair of the valve [1,8]. Three types of mitral
valve dysfunction are defined based on the maximal
movement of the free edge of the leaflet during systole rel-
ative to the plane of the mitral annulus (the line joining
the points of attachment of the valve leaflets to the annu-
lus; Fig 6):
Type I: normal leaflet motion (annular dilatation, leaflet per-
foration).
Type II: increased leaflet motion (mitral valve prolapse, rup-
tured/elongated chordae or papillary muscle).
Imaging a thin structure or boundary using a relatively thick slice Figure 2
Imaging a thin structure or boundary using a relatively thick slice. Because the voxels that contribute to a CMR cine 
image are elongated, their length being the thickness of the slice, orthogonal orientation of the slice relative to a thin structure 
or boundary depicts the structure more clearly than oblique orientation. This principle is fundamental to the strategies 
described in this paper for the imaging of the mitral leaflets and associated regurgitant jets.Journal of Cardiovascular Magnetic Resonance 2008, 10:61 http://www.jcmr-online.com/content/10/1/61
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Type IIIa: restricted leaflet motion in systole and diastole
(chordal or papillary muscle fusion or thickening from
rheumatic valve disease).
Type IIIb: restricted leaflet motion in systole (functional
mitral regurgitation due to tethering of mitral leaflet(s)
from LV dysfunction and/or dilatation from myocardial
infarction or non ischemic cardiomyopathy).
Type II dysfunction, as seen in mitral valve prolapse, is
present when the free edge of the valve leaflet moves at
least 2 mm above the plane of the mitral annulus during
LV systole (Fig 6, see also additional file 1: Figure 6b
movie). This results in an eccentric regurgitant jet directed
away from the leaflet that is prolapsing. Posterior leaflet
prolapse results in an anteriorly directed jet while anterior
leaflet prolapse results in a posteriorly directed jet. Type III
dysfunction is present when the normal or expected max-
imal leaflet movement is restricted. It is easily appreciated
Slices taken across the mitral valve Figure 3
Slices taken across the mitral valve. 5 mm thick slices are taken starting from the superior (antero-lateral) commissure 
(A1-P1) and moving towards the inferior (postero-medial) commissure (A3-P3) at 5 mm intervals. The orientation of the slice 
is parallel to the LVOT slice.Journal of Cardiovascular Magnetic Resonance 2008, 10:61 http://www.jcmr-online.com/content/10/1/61
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when severe as is typical in Type IIIa dysfunction due to
rheumatic mitral valve disease. Less severe leaflet restric-
tion occurring only during systole, as seen in Type IIIb
dysfunction from myocardial infarction or cardiomyopa-
thy, may be more difficult to appreciate by CMR unless
one is familiar with the normal motion of the mitral valve
leaflets and annulus. Measurements of the tethering dis-
tance from the mitral leaflet coaptation point to the mitral
annulus plane can be helpful [11]. Leaflet restriction is
suggested if no leaflet prolapse is identified despite the
presence of an eccentric regurgitant jet. Leaflet restriction
typically results in a regurgitant jet in the same direction
as the leaflet restriction. For example, posterior leaflet
restriction in ischemic mitral regurgitation usually results
in a posteriorly directed regurgitant jet, while anterior
leaflet restriction results in an anteriorly directed jet. If
both leaflets are restricted, as is typical in dilated cardio-
myopathy, a central jet of mitral regurgitation is more
likely.
Additional imaging slices at each end of the mitral valve Figure 4
Additional imaging slices at each end of the mitral valve. A further pair of slices orthogonal to the coaptation plane of 
the valve leaflets is taken at the commissures at each end of the mitral valve (A1-P1 and A3-P3) to better visualise these scal-
lops.Journal of Cardiovascular Magnetic Resonance 2008, 10:61 http://www.jcmr-online.com/content/10/1/61
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Images obtained of each scallop of the mitral valve Figure 5
Images obtained of each scallop of the mitral valve. Each scallop of both mitral valve leaflets is clearly visualised: (a) A1-
P1, (b) A2-P2, (c) A3-P3. Moderate centrally directed mitral regurgitation is seen most marked at (b) A2-P2 due to leaflet 
restriction following myocardial infarction.
Prolapse of P2 causing mitral regurgitation Figure 6
Prolapse of P2 causing mitral regurgitation. (a) A1-P1, (b) A2-P2, (c) A3-P3. Arrowhead shows the posterior leaflet. This 
can be seen to be prolapsed at (b) P2. The yellow line shows the mitral annular plane. The arrows show the eccentric jet of 
mitral regurgitation which results from failure of coaptation of A2-P2 and is anteriorly directed along the wall of the left atrium. 
The white arrow points to a central bright jet core in the A2-P2 bSSFP image, with a dark streak of signal loss beyond (grey 
arrow). This is in accord with relatively severe regurgitation.Journal of Cardiovascular Magnetic Resonance 2008, 10:61 http://www.jcmr-online.com/content/10/1/61
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Quantification of mitral regurgitation severity
Quantification of the severity of mitral regurgitation using
CMR has been previously described [5-7]. The mitral
regurgitant volume (MRV) is the difference between the
LV stroke volume (LVSV) and the aortic forward stroke
volume (AoSV) i.e. MRV (mls/beat) = LVSV – AoSV. The
regurgitant fraction (RF) is the ratio of the MRV divided by
the LVSV i.e. RF (%) = (MRV ÷ LVSV) × 100. This method
of quantifying mitral regurgitation applies even in the
presence of aortic regurgitation as long as only the systolic
forward flow in the aorta is taken as the AoSV. Calculation
of aortic flow using phase-contrast velocity flow mapping
is well established but care must be taken to perform this
optimally [9,12-14]. As a quality control, we ensure that
the aortic forward flow is within 5% of the main pulmo-
nary artery forward flow; the two values should be nearly
equal in the absence of an intra-cardiac shunt. It may also
be possible to directly measure mitral inflow volume by
phase-contrast velocity flow mapping at the tips of the
mitral valve leaflets but this requires a specialised imaging
sequence which tracks the motion of the mitral valve
annulus during the cardiac cycle [15].
In the absence of other regurgitant lesions, MRV can also
be calculated by subtracting the right ventricle stroke vol-
ume (RVSV) from the LVSV i.e. MRV = LVSV – RVSV, using
established techniques [3]. However, the calculation of
RVSV is less reproducible compared to LVSV due to the
extensive trabeculation of the right ventricle (RV). Moreo-
ver, associated tricuspid regurgitation is reported in up to
50% of patients with significant mitral regurgitation and
this invalidates the use of RVSV to determine MRV [16].
The American College of Cardiology has established
echocardiographic criteria for grading the severity of
mitral regurgitation [1]. There are not yet established cri-
teria for grading by CMR. However, regurgitant fractions
(RF) calculated from CMR acquisitions have been corre-
lated with echocardiographic grading in 83 patients with
mitral regurgitation [5], although relatively few of these
had more than moderate regurgitation. In the absence of
established criteria for CMR, the findings of this study,
derived from LV volume and ascending aortic flow meas-
urements, can be noted: mild = RF ≤ 15%, moderate = RF
16–24%, moderate-severe = RF 25–42%, severe = RF >
42%.
Qualitative grading of mitral regurgitation severity
Because the methods we suggest for quantifying mitral
regurgitation by CMR rely on more than one set of meas-
urements, each of which could contribute to inaccuracy if
not optimally performed, it is important to support quan-
titative measurements with a qualitative visual assessment
of severity. In our experience the contiguous stack of
bSSFP cine acquisitions is well suited for this. Although
the bSSFP sequences, with very short echo times, show
only limited signal loss from turbulent regions, the non-
velocity compensated sequence results in loss of signal
from voxels located in the shear layers on either side of the
core of high velocity jets. This is explained by dephasing
of signal from voxels containing a wide range of velocities
in the shear layer bounding a jet. In contrast to the dark
shear layer voxels, bSSFP voxels lying within a coherent jet
core, if present, show bright signal (Fig 6b, see also addi-
tional file 1: Figure 6b movie). For these reasons, suitably
aligned bSSFP slices, either aligned with or transecting the
jet, can show the width of any coherent jet core, which
reflects the width of the regurgitant orifice (Appendix).
Whereas the jets of mild mitral regurgitation will be too
narrow to give bright central voxels, jet(s) of severe mitral
regurgitation are likely to include jet core(s) either broad
enough to give bright central voxels outlined by dark, or
else extensive enough along the line of failed coaptation
to be visible in several slices of the cine stack. In either
case, a bSSFP cine aligned to transect the regurgitant jet
core may also be valuable to assess the cross sectional
extent of each jet. The principle illustrated in Fig 2 applies
to the depiction of jet boundaries as well as leaflets. A fur-
ther feature of severe mitral regurgitation is reversal of
flow in the pulmonary veins during LV systole, which may
be visible in the 4 chamber and certain mitral stack cines.
Discussion
In this paper we have described the methods that we have
used to assess mitral regurgitation by CMR in 149 patients
over a period of 15 months. The etiologies of mitral regur-
gitation were varied with 42% due to ischemia or infarc-
tion, 41% degenerative, 9% due to rheumatic valve
disease and 8% due to cardiomyopathy. We initially used
this systematic imaging technique on a research study on
ischemic mitral regurgitation (hence the large proportion
of patients with ischemic mitral regurgitation), and found
it to be informative and easy to perform, and now use it
routinely. The methods described allow determination of
the severity of mitral regurgitation, mitral valve dysfunc-
tion, LV volumes and function, and, when relevant, LV
viability [2,3,5-7]. Evaluation of mitral valve dysfunction
from standard, routinely acquired CMR imaging planes
alone is rarely adequate. The technique we describe, with
additional imaging of the mitral valve based on its anat-
omy, allows more detailed evaluation of its dysfunction.
We have found such a systematic evaluation of the mitral
valve to be valuable for all etiologies of valve dysfunction.
In degenerative valve disease, it allows determination of
the leaflet scallop responsible for the valve dysfunction
e.g. P2 or P3 prolapse, and hence helps guide surgical
repair. In rheumatic valve disease, it allows assessment of
the severity of valve restriction and hence helps determine
the feasibility of valve repair and the need for valve
replacement. In functional mitral regurgitation due toJournal of Cardiovascular Magnetic Resonance 2008, 10:61 http://www.jcmr-online.com/content/10/1/61
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ischemic heart disease or cardiomyopathy, it confirms the
diagnosis and helps exclude coexisting degenerative valve
disease. A proportion of patients with ischemic heart dis-
ease and mitral regurgitation have coexisting ischemic
heart disease and degenerative mitral regurgitation, and
not ischemic mitral regurgitation. It is important to distin-
guish between the two as functional ischemic mitral
regurgitation may improve with only coronary revascular-
isation without a mitral valve repair but this would not be
true for degenerative mitral regurgitation.
Comparison of the accuracy and reproducibility of CMR
using this technique with echocardiography, especially
transesophageal echocardiography, and findings at sur-
gery will need to be done. Two recent studies using similar
techniques as described here, but without the additional
slices taken at the commissural ends of the mitral valve,
have recently been published [17,18]. The first study
reported a sensitivity and specificity of 89% and 88%
respectively for detecting flail or prolapsed leaflets com-
pared to findings at surgery in 47 patients. This compared
with a sensitivity and specificity of 93% and 88% respec-
tively for transesophageal echocardiography [17]. The sec-
ond study reported agreement between CMR assessment
and transthoracic echo determination of prolapsed or flail
leaflets in 92% of 27 patients [18]. Although these studies
involved only small numbers of patients, the results are
encouraging given that the approach is new, and likely to
improve with experience. We have found the additional
slices acquired adjacent to the valve commissures to con-
tribute to the visualisation of the valve leaflets in this
region where, due to oblique relative orientation, they
may be imperfectly seen in the mitral cine stack. These
additional slices are useful in diagnosing A1/P1 or A3/P3
leaflet prolapse and also in diagnosing functional ischae-
mic mitral regurgitation where leaflet restriction is usually
most marked at P3.
It is recognised that transesophageal echocardiography
assesses the mechanisms of valve dysfunction well (leaflet
prolapse/restriction) and is perhaps the technique best
able to determine the structural lesion responsible for the
incompetence (chordal/papillary muscle rupture/elonga-
tion, leaflet perforation, etc). The fixed imaging planes of
CMR and its suboptimal through-plane resolution rarely
permit adequate visualisation of the chordal structures to
identify rupture or elongation accurately. CMR is also not
suited for visualisation of leaflet and annular calcification
which are important factors influencing the probability of
successful valve repair. Transesophageal echocardiogra-
phy, however, is operator dependent and is a semi-inva-
sive investigation usually requiring patient sedation and
may therefore be less desirable in some patients. Tran-
sthoracic echocardiography, although non-invasive, is
also operator dependent and does not always provide ade-
quate diagnostic images of valve dysfunction, particularly
in patients with excess body mass. Localisation of valve
defects to individual valve scallops can be difficult with
transthoracic echocardiography. CMR, when used opti-
mally, may therefore play a useful role in assessing the
mitral valve in patients in whom transthoracic echocardi-
ography has not provided adequate imaging and in whom
transesophageal echocardiography is considered too inva-
sive. It may also be useful to complement echocardiogra-
phy in establishing the diagnosis when inadequately
achieved by echocardiography. The accuracy of CMR in
determining LV volumes, function and viability may be
particularly useful.
Conclusion
Comprehensive assessment of mitral regurgitation
requires assessment of: (1) its severity to determine the
need for surgical intervention (mild/moderate/severe:
MRV and RF); (2) the mechanism of the dysfunction to
determine the type of surgical intervention required (leaf-
let prolapse/restriction, including the leaflet scallops
involved: A1-P1, A2-P2, A3-P3); (3) LV volumes and func-
tion to determine the timing and risks of surgery; and, in
ischemic mitral regurgitation, (4) LV viability. Such com-
prehensive assessment is feasible in a single CMR exami-
nation but needs a defined protocol, as described in this
paper. When used optimally, CMR can complement exist-
ing imaging modalities such as echocardiography in the
assessment of patients with mitral regurgitation.
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Recommended CMR protocol for the assessment of
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(1) Scout images, including transaxial and coronal mult-
islice stacks.
(2) Standard ventricular cines acquisitions using bSSFP:
￿ Vertical long axis (2 chamber)
￿ Basal short axis scout cine(s)
￿ Four chamber, aligned through LV apex and the centres
of mitral and tricuspid valves.
￿ LVOT (3 chamber) and coronal LVOT cross cut cine
￿ Aortic valve cine, in the plane of aortic valve coaptation
￿ Oblique sagittal RVOT cine
￿ Short axis cine stack for ventricular volume measure-
ment
(3) Mitral cine stack using bSSFP:
5 mm slice thickness with no inter-slice gaps. The orienta-
tion is perpendicular to the central part of the line of
mitral coaptation and approximately parallel to the LVOT
or 3 chamber cine. After alignment, the first slice is placed
through the most superior mitral commissural point, as
seen in basal short axis cines. The remaining 8–10 slices
are acquired sequentially through A1-P1, A2-P2, and A3-
P3 mitral scallops, continuing to just beyond the more
inferior commissure.
(4) Additional commissural cines are acquired perpen-
dicular to the lines of coaptation adjacent to each of the
commissures, if these are oblique to the central coaptation
line.
(5) Cine(s) aligned to transect each mitral regurgitant
jet, located immediately atrial of the regurgitant orifice.
Spatial resolution should be optimised. This approach
can help to demonstrate severity in occasional cases where
there is a discrete and coherent regurgitant jet core.
Through-plane velocity mapping, with appropriate VENC,
may also be used, although the spatial resolution is likely
to be suboptimal.
(6) Through-plane velocity mapping of aortic and pul-
monary flow, VENC as low as possible without aliasing
(typically 150 cm/s, but more if necessary).
Additional, if indicated in ischemic mitral regurgitation:
(7)  Late gadolinium enhancement inversion recovery
imaging to determine myocardial viability.
(8) Low dose dobutamine cine imaging to assess con-
tractile reserve.
Coronary angiography using a fat suppressed 3-D bSSFP
diaphragm navigator acquisition, if indicated, to visualise
the proximal coronary arterial courses.
Additional material
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